Zolinza

Zolinza Warnings and Precautions

• Thromboembolism: Pulmonary embolism and deep vein thrombosis have been reported. Patients should be monitored for related signs and symptoms.
• Myelosuppression: Dose-related thrombocytopenia and anemia can occur. Blood counts should be monitored every 2 weeks initially, then monthly.
• Gastrointestinal toxicity: Nausea, vomiting, and diarrhea are common and may require antiemetics and fluid replacement to prevent dehydration.
• Hyperglycemia: Can occur, sometimes severely. Blood glucose should be monitored every 2 weeks initially, then monthly.
• Electrolyte abnormalities: Serum electrolytes, creatinine, magnesium, and calcium should be monitored, and deficiencies corrected before treatment.
• Interaction with other HDAC inhibitors: Concomitant use with other HDAC inhibitors, such as valproic acid, has been associated with severe thrombocytopenia and gastrointestinal bleeding.
• Embryo-fetal toxicity: Zolinza can cause fetal harm. Effective contraception is required during treatment and for 6 months after the last dose (for women).

How to Access Zolinza in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Zolinza to India?

Zolinza (vorinostat) capsules may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified doctor
• The patient's diagnostic reports
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Zolinza available in India?

Zolinza (vorinostat capsules) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Zolinza is not commercially marketed in India.

However, patients in India can legally access Zolinza through the Named Patient Program (NPP) — an import provision that allows a medicine not yet registered in India to be imported in the name of a specific patient for their personal treatment, under a valid prescription.

Zolinza received US FDA approval in 2006, ensuring full transparency throughout the process.

Zolinza can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.

Sourcing & Delivery

NamedPatientProgram.com (NPP) can source Zolinza from reliable global channels and facilitate supply to patients, doctors, and hospitals under applicable legal provisions. Zolinza capsules should be stored at 20°C to 25°C, with excursions permitted between 15°C and 30°C, and are handled under temperature-controlled shipping conditions throughout transit. All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.

For Zolinza cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.

Availability of Zolinza Across Major Cities in India

Patients across India can access Zolinza through regulated import pathways, with delivery arranged to the treating hospital based on a valid oncologist's prescription.

Mumbai

A major oncology hub with institutions like Tata Memorial, Mumbai coordinates access to advanced lymphoma therapies like Zolinza for eligible patients.

Delhi

As part of the Delhi NCR region, the city has a strong concentration of cancer centers, making it a key location for accessing targeted lymphoma treatments.

Bangalore

With a growing network of multispecialty oncology hospitals, Bangalore supports access to Zolinza through structured import pathways guided by treating specialists.

Chennai

Home to several reputed cancer treatment centers, Chennai facilitates access to Zolinza for patients with cutaneous T-cell lymphoma.

Hyderabad

A growing hub for oncology care, Hyderabad supports coordinated access to Zolinza for eligible patients under specialist supervision.

Kolkata

Eastern India's leading cancer centers in Kolkata coordinate Zolinza access for patients with advanced lymphoma.

Pune

With an expanding base of oncology clinics, Pune facilitates timely access to Zolinza under prescription.

Ahmedabad

Gujarat's leading cancer hospitals support regulated access to Zolinza for eligible patients.

Kochi

Kerala's healthcare network, including major cancer centers in Kochi, coordinates access to advanced oncology therapies like Zolinza.

Chandigarh

Serving North India, Chandigarh's oncology centers facilitate access to Zolinza for patients from Punjab, Haryana, and Himachal Pradesh.

Jaipur

Rajasthan's leading hospitals support patient access to Zolinza through the Named Patient Program.

Lucknow

A key referral center for North India, Lucknow facilitates coordinated access to Zolinza under oncologist care.

Bhubaneswar

Odisha's growing oncology sector supports patient access to Zolinza.

Guwahati

As a referral hub for the North-East, Guwahati facilitates access to Zolinza for patients across the region.

Access can also be coordinated for patients in other major Indian cities, subject to a valid prescription and regulatory requirements.